Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids
Nature Medicine2015Vol. 21(11), pp. 1364–1371
Citations Over TimeTop 1% of 2015 papers
Ling Huang, Audrey Holtzinger, Ishaan Jagan, Michael D. BeGora, Ines Lohse, Nicholas Ngai, M. Cristina Nostro, Rennian Wang, Lakshmi Muthuswamy, Howard C. Crawford, C.H. Arrowsmith, Steve E. Kalloger, Daniel J. Renouf, Ashton A. Connor, Sean P. Cleary, David F. Schaeffer, Michael H. A. Roehrl, Ming‐Sound Tsao, Steven Gallinger, Gordon Keller, Senthil K. Muthuswamy
Related Papers
- → Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.(2020)3 cited
- → Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer(2020)2 cited
- → [Research progress on vascularization of organoids].(2023)1 cited
- → Passaging cancer organoid cultures v1(2020)
- → 127P RAS, RAF and NF1 oncogenic mutations in KRAS-mutated lung adenocarcinoma(2022)